Brief: Adaptive Biotechnologies Reports First Quarter 2023 Financial Results
03/05/2023 21:59
May 3 (Reuters) - Adaptive Biotechnologies Corp
ADPT.O :
* ADAPTIVE BIOTECHNOLOGIES REPORTS FIRST QUARTER 2023
FINANCIAL
RESULTS
* ADAPTIVE BIOTECHNOLOGIES - EXPECT 2023 OPERATING EXPENSES,
INCLUDING COST OF REVENUE, TO BE BELOW FULL YEAR 2022 OPERATING
EXPENSES OF $385.5 MILLION
Source text for Eikon: ID:nGNXwdtfG
Further company coverage: ADPT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adaptive Biotechnologies
See all newsAdvisory: Alert incorrectly tagged to Adaptive Biotechnologies withdrawn
U.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Adaptive Biotechnologies Corp reports results for the quarter ended June 30 - Earnings Summary
Adaptive Biotechnologies Q2 revenue rises 22%, beats estimates